Exact Sciences: Finding the Exact Price to Buy the Stock

Let's check the charts and indicators to see if this a good time and location to go long EXAS.

3 Small Biotechs With Favorable Risk Vs. Reward Profiles

BioDelivery Sciences International, Chiasma Inc. and TherapeticsMD all feature promising treatments.

Centene Shows Improvement After a Long Decline

Downside momentum has been slowing in the healthcare company's shares, which could foreshadow a low or a reversal.

Iovance Biotherapeutics: Technical Analysis and Strategy

Let's check out the charts and indicators of IOVA.

Medtronic Hits Our Price Target: Time to Take Profits?

A follow-up to our story in June.

2 Downtrodden Small Biotechs That Are Showing Signs of Life

T2 Biosystems and Replimune Group have spurted higher in the last couple weeks, with the former doubling in value on encouraging news.

With CVS, Bulls Still Have Their Work Cut Out for Them

The company appears to be combating the risk of possible cost-cutting reform with their continued diversification.

Separating Quality Dividend-Paying Companies From the Wannabes: Part 2

We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.

CVS Health Continues to Move Higher - New Stop Recommendation

CVS continues to move in the right direction for the bulls.

Planet Fitness Shares May Shed Some Big Weight

In the past three years, PLNT bulked up from $20 to $80 and now a major correction to the $50 area -- a 50% correction -- would not be a surprise.